Back to search

Interleukin-2 or autologous lymphokine-activated killer cell treatment of malignant glioma: phase I trial.

Data up to Jan 2025

Published1986
Citations132
References0

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
Interleukin-2 or autologous lymphokine-activated killer cell treatment of malignant… (1986) – PubMed | Metascience Observatory Explorer